NF1 and malignant peripheral nerve sheath tumor: Interestingly, patients with NF1 microdeletion have a 16–26% risk of developing MPNST [9] (compared to an 8–13% risk of developing MPNST for NF1 patients regardless of the specific NF1 mutation [10]).